| Literature DB >> 32139597 |
Lucas M Wiggenhauser1, Haozhe Qi1, Sandra J Stoll1, Lena Metzger1, Katrin Bennewitz1, Gernot Poschet2, Guido Krenning3, Jan-Luuk Hillebrands4, Hans-Peter Hammes5, Jens Kroll6.
Abstract
Progression from the initial vascular response upon hyperglycemia to a proliferative stage with neovacularizations is the hallmark of proliferative diabetic retinopathy. Here we report on the novel diabetic pdx1 -/- zebrafish mutant as model for diabetic retinopathy that lacks the transcription factor pdx1 via CRISPR/Cas9-mediated gene knockout leading to disturbed pancreatic development and hyperglycemia. Larval pdx1 -/- mutants prominently show vasodilation of blood vessels via increased vascular thickness in the hyaloid network as direct developmental precursor of the adult retinal vasculature in zebrafish. In adult pdx1 -/- mutants, impaired glucose homeostasis induces increased hyperbranching and hypersprouting with new vessel formation in the retina and aggravation of the vascular alterations from the larval to the adult stage. Both vascular aspects respond to antiangiogenic and antihyperglycemic pharmacological interventions in the larval stage and are accompanied by alterations in the nitric oxide metabolism. Thus, the pdx1 -/- mutant represents a novel model to study mechanisms of hyperglycemia-induced retinopathy wherein extensive proangiogenic alterations in blood vessel morphology and metabolic alterations underlie the vascular phenotype.Entities:
Year: 2020 PMID: 32139597 DOI: 10.2337/db19-0873
Source DB: PubMed Journal: Diabetes ISSN: 0012-1797 Impact factor: 9.461